| Literature DB >> 35252975 |
Sylvia Owusu-Ansah1, Matthew Harris2, Jennifer N Fishe3, Kathleen Adelgais4, Ashish Panchal5, John W Lyng6, Kerry McCans7, Rachel Alter8, Amanda Perry9, Angelica Cercone1, Phyllis Hendry3, Mark X Cicero10.
Abstract
OBJECTIVES: The COVID-19 pandemic has had an impact on emergency medical services (EMS) and its guidelines, which aid in patient care. This study characterizes state and territory EMS office recommendations to EMS statewide operational and clinical guidelines and describes the mechanisms of distribution and implementation during the COVID-19 pandemic.Entities:
Keywords: COVID‐19; EMS; dissemination; guidance; implementation; pandemic; protocol; statewide
Year: 2022 PMID: 35252975 PMCID: PMC8886181 DOI: 10.1002/emp2.12687
Source DB: PubMed Journal: J Am Coll Emerg Physicians Open ISSN: 2688-1152
FIGURE 1Flow diagram of states and territories included in phases 1 and 2. Of the states, 63% had COVID‐19 emergency medical services protocols in place (33/52). This includes states that may not have written their own protocols but directly referenced the Centers for Disease Control and Prevention emergency medical services protocols as recommendations. One change was made with verification
FIGURE 2States and territories with publicly available COVID‐19 protocols or guidance (n = 33; in orange). All 56 states and territories were assessed, and 4 territories had no office of emergency medical services publicly available online presence (Guam, Northern Mariana Islands, American Samoa, and United States Virgin Islands; in dark gray)
Operational and clinical EMS recommendations from phase 1 evaluation stratified by states/territories with and without statewide publicly available COVID‐19–specific guidance
| No publicly statewide available COVID‐19 guidance ( | Publicly statewide available COVID‐19 guidance ( | |
|---|---|---|
|
| ||
| Patient triage/dispatch | 7/19 (37) | 28/33 (85) |
| PPE recommendations | 9/19 (47) | 32/33 (97) |
| EMS personnel COVID‐19 exposure | 11/19 (58) | 27/33 (82) |
| Alternative destination transport | 6/19 (32) | 9/33 (27) |
| Non‐transport guidance | 4/19 (21) | 14/33 (42) |
| Non‐transport information sheet | 2/19 (11) | 10/33 (30) |
|
| ||
| Airway management procedures | ||
| Aerosolizing procedures | 7/19 (37) | 22/33 (67) |
| Nebulized medications | 6/19 (32) | 15/33 (45) |
| Intubation (airway) | 6/19 (32) | 20/33 (61) |
| Resuscitation guidance | 2/19 (11) | 11/33 (33) |
| Termination of resuscitation | 1/19 (5) | 5/33 (15) |
| Pediatric guidance | 1/19 (5) | 6/33 (18) |
| Febrile illness | 1/19 (5) | 4/33 (12) |
| STEMI management | 0/19 (0) | 1/33 (3) |
| CVA/stroke management | 0/19 (0) | 0/33 (0) |
| Seizure | 0/19 (0) | 0/33 (0) |
|
| ||
| Reference to CDC guidance | 1/19 (5) | 16/33 (48) |
Abbreviations: CDC, Centers for Disease Control and Prevention; CVA, cerebrovascular accident; EMS, emergency medical services; PPE, personal protective equipment; STEMI, ST‐segment–elevation myocardial infarction.
* P < 0.05.
Operational and clinical changes reported by states/territories during interviews (phase 2) stratified by publicly available statewide COVID‐19 guidance
| Guidance topics | No publicly available statewide COVID‐19 guidance, frequency (%) | Publicly available statewide COVID‐19 guidance, frequency (%) |
|---|---|---|
| Operational | ||
| PPE | 9/9 (100) | 22/22 (100) |
| Non‐transport of patients | 6/9 (67) | 16/22 (73) |
| Ambulance cleaning procedures | 5/9 (56) | 18/22 (82) |
| Transport destination | 4/9 (44) | 13/22 (59) |
| Clinical | ||
| Adult respiratory distress | 6/7 (86) | 13/19 (68) |
| Adult COPD/asthma | 4/7 (57) | 13/19 (68) |
| Pediatric respiratory distress | 5/7 (71) | 14/19 (74) |
| Pediatric asthma | 4/7 (57) | 13/19 (68) |
| Airway management/RSI | 5/7 (71) | 16/19 (84) |
| Cardiopulmonary resuscitation | 3/7 (43) | 14/19 (74) |
| Termination of resuscitation | 3/7 (43) | 12/19 (63) |
Abbreviations: COPD, chronic obstructive pulmonary disease; PPE, personal protective equipment; RSI, rapid sequence intubation.
In phase 2 interviews, 31 states reported operational changes, whereas 26 states reported clinical changes.